Clinical Trial Update: Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA) [Phase 4]

View source ↗

Summary

Phase 4 trial update for infliximab as induction therapy in early rheumatoid arthritis has completed enrollment and study completion status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: University of Leeds | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED